-
Editorial Comment to Regulatory News
Hollak, C. E. M. & Bouwhuis, N., 1 Jul 2025, In: Journal of inherited metabolic disease. 48, 4, e70071.Research output: Contribution to journal › Editorial* › Academic › peer-review
-
Product Development of High-Dose Ambroxol HCl Capsules for an n-of-1 Clinical Trial Involving Dutch Patients with Gaucher Disease Type 3
le, H. L., Bouwhuis, N., Hollak, C. E. M., Wilhelm, A. J., Gerards, A.-L. E., Bijleveld, Y. A. & Swart, E. L., 1 Apr 2025, In: Pharmaceutics. 17, 4, 417.Research output: Contribution to journal › Article* › Academic › peer-review
-
Challenges in the identification and quantification of an unknown impurity in chenodeoxycholic acid drug substance
Bouwhuis, N., Polak, Y., Schimmel, A. M., Bijleveld, Y. A., Giera, M. A., Heijink, M., Vaz, F. M., Bootsma, A. H., Berg-Lammers, L. A. T., Swart, N. E. L., Hollak, C. E. M., Jacobs, B. A. W. & Kemper, E. M., 1 Feb 2025, In: European journal of pharmaceutical sciences. 205, p. 106979 106979.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
